Website stats for Deciphera - deciphera.com
Ron’s Story“There have been a lot of ups and downs of my journey and sometimes I get a little frightened but through it all I’ve tried to stay positive. To be honest, it’s difficult sometimes but I feel the longer I fight, the more opportunity there is for future medical solutions. My goal is to hang around long enough so that when researchers are successful, I’m successful. Hope is, and always wi...
deciphera.com was registered 2 decades 2 years ago. It has a alexa rank of #1,262,861 in the world. It is a domain having .com extension. It is estimated worth of $ 960.00 and have a daily income of around $ 4.00. As no active threats were reported recently, deciphera.com is SAFE to browse.
Traffic Report
| Daily Unique Visitors: | 694 |
| Daily Pageviews: | 1,388 |
Estimated Valuation
| Income Per Day: | $ 4.00 |
| Estimated Worth: | $ 960.00 |
Search Engine Indexes
| Google Indexed Pages: | Not Applicable |
| Yahoo Indexed Pages: | Not Applicable |
| Bing Indexed Pages: | Not Applicable |
Search Engine Backlinks
| Google Backlinks: | Not Applicable |
| Bing Backlinks: | Not Applicable |
| Alexa BackLinks: | Not Applicable |
Safety Information
| Google Safe Browsing: | No Risk Issues |
| Siteadvisor Rating: | Not Applicable |
| WOT Trustworthiness: |
 Very Poor
|
| WOT Privacy: |
Very Poor
|
| WOT Child Safety: |
Very Poor
|
Website Ranks & Scores
| Alexa Rank: | 1,262,861 |
| PageSpeed Score: | 89 ON 100 |
| Domain Authority: |
49 ON 100 
|
| Bounce Rate: | Not Applicable |
| Time On Site: | Not Applicable |
Web Server Information
Hosted IP Address:
192.241.148.226
Hosted Country:
US
Location Latitude:
40.8043Location Longitude:
-74.0121Traffic Classification
| Total Traffic: | No Data |
| Direct Traffic: | No Data |
| Referral Traffic: | No Data |
| Search Traffic: | No Data |
| Social Traffic: | No Data |
| Mail Traffic: | No Data |
| Display Traffic: | No Data |
Search Engine Results For deciphera.com
Home - Deciphera Pharmaceuticals, Inc.
Our Pipeline. Enabled by our proprietary switch-control kinase inhibitor platform, we have built a diverse pipeline of wholly-owned, orally administered drug candidates that...
Investors Overview | Deciphera Pharmaceuticals, Inc.
Deciphera Pharmaceuticals is a clinical-stage biopharmaceutical company focused on improving the lives of cancer patients by addressing key mechanisms of tumor and drug...
Deciphera Pharmaceuticals to Present at the 39th Annual J ...
Jan 05, 2021 · WALTHAM, Mass.--(BUSINESS WIRE)--Jan. 5, 2021-- Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) today announced that Steve Hoerter, President and Chief Executive...
Deciphera AccessPoint Patient Access and Support
Information on financial support and resources for Deciphera products including help getting access to QINLOCK™ (ripretinib).
Deciphera Presents Updated Preliminary Data from DCC-3014 ...
Nov 11, 2020 · Deciphera Presents Updated Preliminary Data from DCC-3014, its CSF1R Inhibitor Program, in Tenosynovial Giant Cell Tumor Patients at the Connective Tissue...
5. Deciphera Pharmaceuticals | FierceBiotech
Oct 19, 2020 · Website: deciphera.com. Cancer drug developers are a perennially popular target for biopharma companies at the moment, and interest tends to intensify as drugs...
Deciphera Pharmaceuticals to Present at the 39th Annual J ...
Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) today announced that Steve Hoerter, President and Chief Executive Officer, will present at the 39th Annual J.P. Morgan Healthcare...
Deciphera Pharmaceuticals to Present at the 39th Annual J ...
Jan 05, 2021 · WALTHAM, Mass.--(BUSINESS WIRE)--Jan. 5, 2021-- Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) today announced that Steve Hoerter, President and Chief Executive...
Deciphera Pharmaceuticals | LinkedIn
Deciphera Pharmaceuticals | 11,582 followers on LinkedIn | Deciphera, a commercial biopharmaceutical company, is decoding cancer at the molecular level and leveraging its...
Getting Enrolled | Deciphera AccessPoint
Why get enrolled? By enrolling in Deciphera AccessPoint, you can get: Insurance support—we can answer questions about insurance, check on your coverage for Qinlock ™...
Deciphera | AldenMC
Deciphera, a Massachusetts clinical stage biotechnology company, was rapidly progressing in the development of their proprietary switch control platform and their diverse...
Deciphera - Overview, News & Competitors | ZoomInfo.com
Deciphera Pharmaceuticals, Inc. to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference WALTHAM, Mass.--(BUSINESS WIRE)--Deciphera Pharmaceuticals, Inc. …
Deciphera Pharmaceuticals - Crunchbase Company Profile ...
Deciphera Pharmaceuticals focuses on improving kinase inhibitor treatments. Deciphera was established in 2003 based on a deep scientific understanding of kinase inhibitors and a...
Deciphera Pharmaceuticals LLC | VentureRadar
"Deciphera Pharmaceuticals is a clinical-stage biopharmaceutical company focused on improving the lives of cancer patients by tackling key mechanisms of drug resistance that...
Deciphera Pharmaceuticals to Present at the 39th Annual J ...
Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) today announced that Steve Hoerter, President and Chief Executive Officer, will present at the 39th Annual J.P. Morgan Healthcare...
Working at Deciphera Pharmaceuticals | Glassdoor
Deciphera is a bio-pharmaceutical company focused on discovering, developing and commercializing important new medicines to improve the lives of people with cancer.
QINLOCK™ (ripretinib) For Healthcare Professionals
Qinlock was studied in a global, Phase 3 study in ≥4 th ‑line GIST 2. The INVICTUS study was a global, multicenter, randomized, double‑blind, placebo‑controlled Phase 3 trial...
Deciphera Presents Data from Rebastinib, its TIE2 ...
Sep 17, 2020 · WALTHAM, Mass.--(BUSINESS WIRE)-- Deciphera Pharmaceuticals LLC. (NASDAQ:DCPH), today announced the presentation of data from the ovarian cancer cohort in Part 2 …
Deciphera Pharmaceuticals, Inc. to Announce Second Quarter ...
About Deciphera Pharmaceuticals. Deciphera is a biopharmaceutical company focused on discovering, developing and commercializing important new medicines to improve the lives of...
Page Resources Breakdown
Homepage Links Analysis
Website Inpage Analysis
| H1 Headings: | 1 | H2 Headings: | 7 |
| H3 Headings: | Not Applicable | H4 Headings: | Not Applicable |
| H5 Headings: | Not Applicable | H6 Headings: | Not Applicable |
| Total IFRAMEs: | Not Applicable | Total Images: | 8 |
| Google Adsense: | Not Applicable | Google Analytics: | UA-2500634-1 |
Two Phrase Analysis
| Words | Occurrences | Density | Possible Spam |
|---|---|---|---|
| Deciphera Pharmaceuticals | 7 | 1.203 % | No |
| in the | 6 | 1.031 % | No |
| of Directors | 4 | 0.687 % | No |
| Board of | 4 | 0.687 % | No |
| Our Pipeline | 4 | 0.687 % | No |
| Our Focus | 4 | 0.687 % | No |
| Focus on | 4 | 0.687 % | No |
| Management Board | 4 | 0.687 % | No |
| on Patients | 4 | 0.687 % | No |
| News Events | 3 | 0.515 % | No |
| Pharmaceuticals Inc | 3 | 0.515 % | No |
| Our Workplace | 3 | 0.515 % | No |
| in our | 3 | 0.515 % | No |
| Gastrointestinal Stromal | 3 | 0.515 % | No |
| Press Releases | 2 | 0.344 % | No |
| Coverage Press | 2 | 0.344 % | No |
| Analyst Coverage | 2 | 0.344 % | No |
| Calculator Analyst | 2 | 0.344 % | No |
| Releases Deciphera | 2 | 0.344 % | No |
| the News | 2 | 0.344 % | No |
Four Phrase Analysis
| Words | Occurrences | Density | Possible Spam |
|---|---|---|---|
| Management Board of Directors | 4 | 0.687 % | No |
| Our Focus on Patients | 4 | 0.687 % | No |
| Information Stock Quote Chart | 2 | 0.344 % | No |
| Stock Information Stock Quote | 2 | 0.344 % | No |
| Investors Stock Information Stock | 2 | 0.344 % | No |
| Team Investors Stock Information | 2 | 0.344 % | No |
| Stock Quote Chart Historical | 2 | 0.344 % | No |
| Chart Historical Price Lookup | 2 | 0.344 % | No |
| Lookup Investment Calculator Analyst | 2 | 0.344 % | No |
| Investment Calculator Analyst Coverage | 2 | 0.344 % | No |
| Price Lookup Investment Calculator | 2 | 0.344 % | No |
| Historical Price Lookup Investment | 2 | 0.344 % | No |
| Our Team Investors Stock | 2 | 0.344 % | No |
| Quote Chart Historical Price | 2 | 0.344 % | No |
| Values Join Our Team | 2 | 0.344 % | No |
| Presentations and Publications Our | 2 | 0.344 % | No |
| and Publications Our Workplace | 2 | 0.344 % | No |
| Platform Presentations and Publications | 2 | 0.344 % | No |
| Control Platform Presentations and | 2 | 0.344 % | No |
| Switch Control Platform Presentations | 2 | 0.344 % | No |
HTTP Header Analysis
Status-Code: 200
Status: 200 OK
Date: Sat, 09 Jan 2021 09:22:49 GMT
Server: Apache/2.4.29 (Ubuntu)
X-Frame-Options: SAMEORIGIN
X-Xss-Protection: 1; mode=block
X-Content-Type-Options: nosniff
Strict-Transport-Security: max-age=31536000; includeSubDomains
Referrer-Policy: same-origin
Link:
Vary: Accept-Encoding
Content-Encoding: gzip
Content-Length: 12764
Content-Type: text/html; charset=UTF-8
Domain Information
| Domain Registrar: |
Register.com, Inc.
|
|---|---|
| Registration Date: | 2002-08-14 2 decades 2 years 3 months ago |
| Last Modified: | 2020-04-21 4 years 6 months 4 weeks ago |
Domain Nameserver Information
| Host | IP Address | Country | |
|---|---|---|---|
| ns10.dnsmadeeasy.com | |
208.94.148.4 | United States |
| ns11.dnsmadeeasy.com | |
208.80.124.4 | United States |
| ns12.dnsmadeeasy.com | |
208.80.126.4 | United States |
| ns13.dnsmadeeasy.com | |
208.80.125.4 | United States |
| ns14.dnsmadeeasy.com | |
208.80.127.4 | United States |
| ns15.dnsmadeeasy.com | |
208.94.149.4 | United States |
Full WHOIS Lookup
Registry Domain ID:
89333453_DOMAIN_COM-VRSN
Registrar WHOIS Server:
whois.register.com
Registrar URL:
http://www.register.com
Updated Date:
2020-04-21T09:30:18Z
Creation Date:
2002-08-14T14:34:29Z
Registry Expiry Date:
2022-08-14T14:34:29Z
Registrar: Register.com, Inc.
Registrar
IANA ID: 9
Registrar Abuse Contact Email:
[email protected]
Registrar Abuse Contact Phone:
+1.8003337680
Domain Status: clientTransferProhibited
https://icann.org/epp#clientTransferProhibited
Name Server:
NS10.DNSMADEEASY.COM
Name Server: NS11.DNSMADEEASY.COM
Name
Server: NS12.DNSMADEEASY.COM
Name Server:
NS13.DNSMADEEASY.COM
Name Server: NS14.DNSMADEEASY.COM
Name
Server: NS15.DNSMADEEASY.COM
DNSSEC: unsigned
URL of the ICANN
Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>>
Last update of whois database: 2021-01-09T09:24:01Z
Similarly Ranked Websites
Cursillos francophones - Cursillo Movement - Cursillos de Cristiandad
site religieux des Cursillos du Canada Français
1,262,866 
$ 960.00
Senior Housing and Assisted Living Software | Eldermark
Eldermark collaborates with care partners to develop senior housing & assisted living software solutions. Streamline data, reduce costs & improve lives today!
1,262,874 $ 960.00
巨匠數位學院-電腦數位線上課程,線上學電腦
巨匠電腦數位學院,學電腦超簡單!提供各種學電腦數位課程包含手機app,工業設計,室內設計及電腦證照考試等,是您學電腦線上數位課程最佳選擇
1,262,891 $ 960.00
أ.د. أحمد محمد وهبان – كلية الدراسات الاقتصادية والعلوم السياسية –...
1,262,894 $ 960.00